In conversation with....

Sanjay Basu on affordable T2D medicine in LMICs

November 16, 2021 The Lancet Diabetes & Endocrinology
In conversation with....
Sanjay Basu on affordable T2D medicine in LMICs
Show Notes

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.

Read the full article:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext